384 related articles for article (PubMed ID: 18836734)
1. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
[TBL] [Abstract][Full Text] [Related]
2. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.
Sone J; Tanaka F; Koike H; Inukai A; Katsuno M; Yoshida M; Watanabe H; Sobue G
Neurology; 2011 Apr; 76(16):1372-6. PubMed ID: 21411744
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K
Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509
[TBL] [Abstract][Full Text] [Related]
4. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains.
Villagra NT; Navascues J; Casafont I; Val-Bernal JF; Lafarga M; Berciano MT
Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395
[TBL] [Abstract][Full Text] [Related]
5. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
[TBL] [Abstract][Full Text] [Related]
6. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.
Liu Y; Mimuro M; Yoshida M; Hashizume Y; Niwa H; Miyao S; Ujihira N; Akatsu H
Acta Neuropathol; 2008 Dec; 116(6):615-23. PubMed ID: 18923837
[TBL] [Abstract][Full Text] [Related]
7. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease.
Pountney DL; Huang Y; Burns RJ; Haan E; Thompson PD; Blumbergs PC; Gai WP
Exp Neurol; 2003 Nov; 184(1):436-46. PubMed ID: 14637113
[TBL] [Abstract][Full Text] [Related]
8. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy.
Pountney DL; Chegini F; Shen X; Blumbergs PC; Gai WP
Neurosci Lett; 2005 Jun 10-17; 381(1-2):74-9. PubMed ID: 15882793
[TBL] [Abstract][Full Text] [Related]
9. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K
Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376
[TBL] [Abstract][Full Text] [Related]
10. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1.
Umahara T; Uchihara T; Yagishita S; Nakamura A; Tsuchiya K; Iwamoto T
Neurosci Lett; 2007 Mar; 414(2):130-5. PubMed ID: 17224237
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.
Woulfe JM
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):2-42. PubMed ID: 17239006
[TBL] [Abstract][Full Text] [Related]
12. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
[TBL] [Abstract][Full Text] [Related]
13. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
[TBL] [Abstract][Full Text] [Related]
14. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
[TBL] [Abstract][Full Text] [Related]
15. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy.
Nishie M; Mori F; Yoshimoto M; Takahashi H; Wakabayashi K
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):546-54. PubMed ID: 15488031
[TBL] [Abstract][Full Text] [Related]
16. Incipient intranuclear inclusion body disease in a 78-year-old woman.
Mori F; Miki Y; Tanji K; Ogura E; Yagihashi N; Jensen PH; Wakabayashi K
Neuropathology; 2011 Apr; 31(2):188-93. PubMed ID: 20667015
[TBL] [Abstract][Full Text] [Related]
17. SUMO on the road to neurodegeneration.
Dorval V; Fraser PE
Biochim Biophys Acta; 2007 Jun; 1773(6):694-706. PubMed ID: 17475350
[TBL] [Abstract][Full Text] [Related]
18. Neuronal intranuclear inclusion disease in a horse.
Pumarola M; Vidal E; Trens JM; Serafín A; Marquez M; Ferrer I
Acta Neuropathol; 2005 Aug; 110(2):191-5. PubMed ID: 15971054
[TBL] [Abstract][Full Text] [Related]
19. Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Ikeda T; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2012 Jul; 124(1):149-51. PubMed ID: 22661321
[No Abstract] [Full Text] [Related]
20. Isolation of pathology-associated intranuclear inclusions.
Iwahashi C; Hagerman PJ
Methods Mol Biol; 2008; 463():181-90. PubMed ID: 18951169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
